Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge in the management of congestive heart failure (CHF). Fluid overload is ...
Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, demonstrated consistent efficacy and safety regardless of diuretic type or dose and reduced overall diuretic requirements in patients ...
CHICAGO, IL—A novel way of taking the loop diuretic bumetanide—by nasal spray—is safe and well tolerated in healthy adults, according to preliminary randomized data. Diuretic concentrations achieved ...
CHICAGO — A nasal spray formulation of bumetanide, a diuretic drug, could help treat heart failure by preventing the resistance that can develop to oral forms of the drug, a preliminary safety and ...
In patients with type 2 diabetes and chronic kidney disease, diuretic use does not affect the safety and efficacy of finerenone. The safety and efficacy of finerenone is not affected by diuretic use ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results